EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Despite lower haemoglobin A1c with second‐generation automated insulin delivery systems, mental burden remains high for all adults with type 1 diabetes: A BETTER registry analysis

Zekai Wu iD, Laure Alexandre-Heymann, Maha Lebbar, Meryem K Talbo iD, Aude Bandini, Tamanna Chahal, Caroline Grou, Virginie Messier, Valérie Boudreau, Anne-Sophie Brazeau iD, Rémi Rabasa-Lhoret iD

Diabetes, Obesity and Metabolism · 2026

DOI: 10.1111/dom.70299 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2026. Verfasst von Zekai Wu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Experimental Medicine, Department of Medicine, McGill University, Montreal, Quebec, Canada. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Glycated Hemoglobin, Insulin Infusion Systems, Insulin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Juvenile Diabetes Research Foundation Canada, Strategy for Patient-Oriented Research, Breakthrough T1D Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

We aim to compare second‐generation automated insulin delivery systems (AIDs) with other treatment modalities regarding both glucose management outcomes and person‐reported outcomes/experiences (PROs/PREs, measured by the Hypoglycemia Fear Survey, Hypoglycemic Confidence Scale, Hyperglycemia Avoidance Scale, Diabetes Distress Scale, Pittsburgh Sleep Quality Index, Well‐being Scale, and treatment satisfaction) among adults with type 1 diabetes. Research design and methods Cross‐sectional analysis of the Canadian BETTER type 1 diabetes registry. Adult participants were divided into five groups: second‐generation AIDs, first‐generation AIDs, continuous glucose monitoring (CGM) + pump, CGM + multiple daily injections (MDI), and non‐CGM using MDI or pump. Generalized linear models were used to assess differences between the second‐generation AID group and each of the other groups, with p < 0.05 considered significant.

Results

Among 1731 participants (69.2% females), mean age was 45.3 ± 15.3 years with 24.7 ± 16.0 years of diabetes. The second‐generation AID group had the highest proportion of achieving target haemoglobin A1c ≤ 7% (58.1%) compared to 40.6% in the first‐generation AID group, 40.5% in the Pump + CGM group, 37.3% in the MDI + CGM group, and 32.3% in the non‐CGM group, even after adjustment for multiple imbalanced characteristics ( p < 0.001). While second‐generation AID users reported higher treatment satisfaction, no other differences in measures of PROs/PREs were found between second‐generation AID and other groups. Elevated diabetes distress (55%) and poor sleep quality (63%) remained common across all treatment groups, and even among those who had reached the optimal HbA1c target (48% and 60%, respectively).

Conclusions

In real‐world settings, second‐generation AIDs were associated with lower haemoglobin A1c and higher treatment satisfaction but not better PROs/PREs. Mental burden remained high despite the use of advanced diabetes technologies and optimal glucose management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1Glycated HemoglobinInsulin Infusion SystemsInsulinHypoglycemic AgentsHumansFemaleMaleCross-Sectional StudiesAdultRegistriesMiddle AgedBlood Glucose Self-MonitoringPatient SatisfactionCanadaHypoglycemiaYoung AdultBlood GlucoseGlycemic ControlPatient Reported Outcome Measures

Stichwörter der Autor:innen

automated insulin delivery systemglucose managementperson‐reported outcomes/person‐reported experiencesreal‐world studytype 1 diabetes

Substanzen

Glycated HemoglobinInsulinHypoglycemic AgentsBlood Glucosehemoglobin A1c protein, human

Autor:innen und Institutionen

  • Division of Experimental Medicine, Department of Medicine, McGill University, Montreal, Quebec, Canada.
  • Montreal Clinical Research Institute, Montreal, Quebec, Canada.
  • School of Human Nutrition, McGill University, Sainte-Anne-de-Bellevue, Quebec, Canada.
  • Division of Endocrinology, Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA.
  • Department of Philosophy, Faculty of Arts and Sciences, Université de Montréal, Montreal, Quebec, Canada.
  • Montreal Diabetes Research Center, Montreal, Quebec, Canada.

ORCID-Profile: Zekai Wu, Meryem K Talbo, Anne-Sophie Brazeau, Rémi Rabasa-Lhoret

Förderung

  • Juvenile Diabetes Research Foundation Canada
  • Strategy for Patient-Oriented Research
  • Breakthrough T1D Canada

Zitieren

APA

Wu, Z., Alexandre-Heymann, L., Lebbar, M., Talbo, M. K., Bandini, A., Chahal, T., Grou, C., Messier, V., Boudreau, V., Brazeau, A. S., & Rabasa-Lhoret, R. (2026). Despite lower haemoglobin A1c with second‐generation automated insulin delivery systems, mental burden remains high for all adults with type 1 diabetes: A BETTER registry analysis. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.70299

Vancouver

Wu Z, Alexandre-Heymann L, Lebbar M, Talbo MK, Bandini A, Chahal T, et al. Despite lower haemoglobin A1c with second‐generation automated insulin delivery systems, mental burden remains high for all adults with type 1 diabetes: A BETTER registry analysis. Diabetes, Obesity and Metabolism. 2026. doi:10.1111/dom.70299

BibTeX
@article{Wu2026,
  author = {Wu, Zekai and Alexandre-Heymann, Laure and Lebbar, Maha and Talbo, Meryem K and Bandini, Aude and Chahal, Tamanna and Grou, Caroline and Messier, Virginie and Boudreau, Valérie and Brazeau, Anne-Sophie and Rabasa-Lhoret, Rémi},
  title = {Despite lower haemoglobin A1c with second‐generation automated insulin delivery systems, mental burden remains high for all adults with type 1 diabetes: A BETTER registry analysis},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  doi = {10.1111/dom.70299}
}
Kostenlos starten →